Please login to the form below

Not currently logged in
Email:
Password:

MedImmune appoints head of research

Yong-Jun Liu to lead R&D at AstraZeneca biologics subsidiary

MedImmune Jong-Jun LiuAstraZeneca (AZ) has strengthened its research team by appointing leading academic Dr Yong-Jun Liu as head of research at its MedImmune subsidiary.

AZ has made of series of pipeline-boosting acquisitions in the past year, but the appointment of Dr Liu is a move to strengthen its existing R&D operations.

Dr Liu joins the company after an extensive career in academia, which most recently saw him serve as VP and chief scientific officer at the Baylor Research Institute and director of the Baylor Institute for Immunology Research.

He also served for a period as chair of the Department of Immunology at the University of Texas.

MedImmune focuses on the development of biologics and will look to benefit from Dr Liu's experience in immunology as it works to develop a portfolio of immunotherapies, including investigational cancer treatments.

Bahija Jallal, executive VP MedImmune, commented on the company's commitment to develop in-house research through strong leadership.

“Scientific leadership is our top priority,” said Jallal. “We are committed to hiring established leaders who will drive our research engine and progress our efforts to deliver valuable medicines to patients.”

18th November 2013

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Fishawack Group of Companies

The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...

Latest intelligence

The other side of … Crohn’s disease
What patients say is their truth about living with chronic conditions. “I want to believe in my doctor but I feel more comfortable getting my guidance elsewhere.”...
OPEN Health brings the Best of Both Worlds to MAPS EMEA 2020
...
1000 Voices Survey
The patient voice is key to creating meaningful changes in healthcare; to drive patients to be more actively involved in their care, which leads to better outcomes. So, we went...

Infographics